A new company focused on gene therapy manufacturing, Advanced Medicine Partners, has been launched in North Carolina, USA.
A spinout from Illinois-based Jaguar Gene Therapy, the new company will deliver process development, manufacturing, analytical development and testing for advanced therapy products.
The firm offers an established development platform as well as a reproducible adeno-associated virus (AAV) manufacturing process.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze